Background and Purpose-Recent studies have investigated plaque morphology to determine patients who are at high risk of carotid atherosclerosis. In this study, we investigated whether a difference in dynamic enhancement pattern in plaque components could be useful to assess plaque stability with multidetector CT angiography. Methods-Fifty-nine lesions with moderate to severe carotid atherosclerosis in 51 patients (33 symptomatic, 18 asymptomatic) were consecutively included. Early-and delayed-phase images were obtained in 3 equivalent axial slices with multidetector CT angiography. Hounsfield units (HU) in the early phase were subtracted from those in the delayed phase in plaques (⌬HU) and compared with clinical features, MRI-based plaque characteristics, and histological findings with 20 surgical specimens acquired from carotid endarterectomy. Results-The ⌬HU was significantly higher in asymptomatic than that in symptomatic presentation (Pϭ0.02). With MRI, a higher ⌬HU was negatively correlated with signal intensity on T1-weighted imaging (rϭϪ0.56, PϽ0.0001). Histology confirmed that ⌬HU was positively correlated with fibrous tissue (rϭ0.67, Pϭ0.001) and negatively correlated with a lipid-rich necrotic core with hemorrhage (rϭϪ0.70, PϽ0.001). Moreover, less neovascularization and inflammation was found in plaques with a higher ⌬HU. Conclusions-Delayed-phase images provide information regarding the dynamic change in contrast media from the early arterial phase. An increase in HU from the early phase on multidetector CT angiography indicates plaque stability with more fibrous tissue and a less lipid-rich necrotic core, intraplaque hemorrhage, and neovascularization. (Stroke. 2012; 43:393-398.)
C
arotid atherosclerosis is 1 of the major causes of cerebral stroke. This can contribute to hemodynamic impairment in intracranial circulation as well as artery-to-artery embolisms. Initially, studies focused on luminal stenosis because the risk of stroke in patients with carotid atherosclerosis is closely associated with the severity of luminal stenosis, and the degree of stenosis is used in therapeutic decision-making for carotid interventions such as carotid endarterectomy or carotid arterial stenting. The widespread use of this measure is primarily based on the results of several randomized clinical trials that demonstrated a reduction in the risk for ischemic stroke in patients with luminal stenosis of Ն70% after carotid endarterectomy compared with medical treatment alone. [1] [2] [3] [4] However, carotid stenosis of Ն70% occurs in Ͻ10% of patients, whereas Ͻ70% of carotid stenosis is extremely frequent in the general population. 5 Recently, studies on carotid atherosclerotic plaques have revealed that plaque morphology could be an important additional feature in the risk assessment of patients with carotid stenosis. 6 -26 Certain morphological features of carotid plaques such as a large lipid-rich necrotic core (LRNC), intraplaque hemorrhage (IPH), neovascularization, inflammation, or thin fibrous caps are increasingly reported to be associated with a heightened risk of stroke. Therefore, the concept of the vulnerable or high-risk plaque, initially derived from coronary studies, has been increasingly shown to be applicable in the carotid circulation.
An increased number of reports have shown promising plaque imaging techniques, including ultrasound, positron emission tomography, MRI, and multidetector CT angiography (MDCTA), which can characterize vulnerable carotid plaque features as well as luminal stenosis. 16 However, it remains unclear which modality is the most effective and reliable. MDCTA is fast emerging as 1 of the noninvasive modalities of choice for carotid stenosis because of its high spatial resolution, speed, and ready availability. However, the use of MDCTA on plaque vulnerability is controversial 8 -11,15,20,26,27 with some reports showing the limitation of evaluating Hounsfield units (HU) for the assessment of carotid plaques owing to the blooming effect of calcification and overlapping between plaque components. 15, 16, 26, 27 Recently, some reports have indicated that a dynamic study with contrast-enhanced MRI can differentiate plaque components such as fibrous tissue with a peak in a delayed venous phase and neovascularization with a peak in an early arterial phase. 24,25,28 -30 This concept is based on the difference in absorption of contrast media in each plaque component and therefore it also could be applied to MDCTA, which has not been performed yet. Moreover, this dynamic study has the potential to address the blooming effect of calcification on MDCTA if HU in the delayed phase are subtracted from those in the early phase.
This study aimed to test (1) whether an increase in HU from early to delayed phases (⌬HU) on MDCTA is correlated with clinical presentation, MRI-based plaque morphology, and histological findings; and (2) to assess the hypothesis that a higher ⌬HU indicates plaque stability with a lot of fibrous tissue and less LRNC, IPH, and neovascularization.
Methods

Study Population
Between April 2009 and December 2010, 59 lesions in 51 patients with Ͼ50% carotid stenosis on MDCTA (according to the North American Symptomatic Carotid Endarterectomy Trial [NASCET]) were consecutively included in this study. The patients were defined as "symptomatic" because they had an anterior circulation stroke or transient ischemic attack within 2 weeks of radiological analysis.
The diagnosis of stroke was based on clinical presentation at admission and positive diffusion-weighted imaging at follow-up. The patients were defined as "asymptomatic" because they had no clinical symptoms and were found to have carotid stenosis in screening for atherosclerosis. Twenty patients underwent carotid endarterectomy based on the NASCET criteria 3 and surgical specimens were analyzed for histology. This study was approved by our Institutional Review Board, and all patients gave written informed consent.
MDCTA Protocol and Analysis
All patients were scanned from the aortic arch to the head using a 64-MDCTA scanner (Aquilion 64 ® ; Toshiba Medical Systems). MDCTA examinations were performed within 2 weeks of the surgical procedure to reduce potential errors in image and histopathologic correlations. Details of the protocol are described in the Supplemental Method (http://stroke.ahajournals.org. Two experienced readers (N.H. and M.M.) blindly rated and measured with free-hand segmentation the region of interest in each carotid plaque at 3 axial slices including the most stenotic site and 3.0 mm proximally and 3.0 mm distally. The mean HU in the region of interest was measured at 2 phases (early and delayed phase with an interval of 2 minutes). The equivalent level of the stenosis and region of interest were automatically defined at the early and delayed phases to avoid misregistration between the 2 phases ( Figure 1A-C) . HU in the early phase were then subtracted from those in the delayed phase (⌬HU) to assess delayed enhancement of the contrast media in relation to clinical, radiological, and histological findings. Severe calcified components covering the vessel wall were excluded from the region of interest. During the image review, the center level was set at 200 HU and window width was at 700 HU in both phases, which allowed for optimal plaque component distinction. Plaque ulceration was defined as outpouching of contrast into the plaque at least 2 mm deep.
MRI Protocol and Analysis
In all the patients, carotid atherosclerotic plaques were imaged in a 1.5-T MRI scanner (Signa; GE Medical System) using a phasedarray coil with a diameter of 3 inches. MRI examinations were also performed within 2 weeks of the surgical procedure. Details of the MRI sequences are described in the Supplemental Method. Three axial slices (including the most stenotic site and 3.0 mm proximal and 3.0 mm distal to the stenosis; these were the same slices analyzed on MDCTA) were selected, and then the mean signal intensity was quantified in the axial plaque area and ipsilateral sternocleidomastoid muscle. The T1-weighted imaging plaque/sternocleidomastoid muscle ratio was calculated for the assessment of LRNC with hemorrhage. 13 The IPH was defined as the signal ratio of time of flight plaque/sternocleidomastoid muscle Ͼ2.0. 13
Histology Sample Processing and Analysis
In the patients who underwent carotid endarterectomy, whole specimens were formalin-fixed, sectioned in 3.0-mm transverse slices, decalcified, and embedded in paraffin. Subsequently, 5.0-m sections (3 sections with an interval of 3.0 mm including most stenotic slices to match the MDCTA and MRI slices) were subjected to histopathologic analysis of plaque phenotype after hematoxylin and eosin, Azan, elastic van Gieson (EVG), Alcian blue staining, and Berlin blue staining. The plaque component of fibrous tissue, or LRNC with hemorrhage, was separately calculated as a mean percentage of the total plaque area in the 3 axial slices (fibrous tissue or LRNC with hemorrhage/total plaque areaϫ100). Fibrous areas were measured on sections stained with Azan and EVG (blue in Azan and pinkish in EVG) and LRNC with hemorrhage areas were measured on sections stained with Azan and EVG (purple in Azan and brown in EVG). Some sections with a massive LRNC were stained with Alcian blue to confirm mucopolysaccharide in the plaque. Neovascularization and inflammation were assessed with hematoxylin and eosin staining (ϫ400). Initially, neovascularization on the shoulder of the plaque was classified as follows: 
Image and Pathology Review and Data Analysis
The MDCTA and MR images were separately analyzed by 2 experienced readers (N.H. and M.M.) by consensus, who were blinded to the radiological, histopathologic, and clinical characteristics. Initially, the readers judged the main plaque components with signal changes for each sequence. According to our diagnostic criteria for plaque components, generally LRNC revealed high signal intensity on T1-weighted imaging and plaques containing IPH revealed high signal intensity on T1-weighted images and time of flight images. 13 The pathological slides were also blindly evaluated by 2 experienced readers (N.H. and G.S.). Statistical analysis was performed with GraphPad Instat (Version 3.05; La Jolla, CA) and SPSS (Version 15.0; SPSS Japan Inc, Tokyo, Japan). The independent samples t test and Fisher exact test were used to compare continuous and categorical characteristics, respectively, between symptomatic and asymptomatic patients. Correlations between MDCTA-based HU and MRI parameters or pathological tissue area (fibrous and LRNC with hemorrhage) were analyzed by the Pearson rank correlation test (which measures the linear relationship between 2 variables), because we expected a linear relationship. Differences were defined as significant at a probability level Ͻ0.05.
Results
Patients' Characteristics
The characteristics of the study population are listed in Table 1 . Among the 51 patients, 33 were symptomatic (24 infarctions, 9 transient ischemic attacks) and 18 were asymptomatic. There were significant differences in some of radiological findings. Initially, the mean degree of stenosis was 82.2%Ϯ12.8% in symptomatic compared with 68.3%Ϯ14.8% in asymptomatic (PϽ0.001) presentation. In 5 cases, severe calcified adventitia was excluded from the region of interest in radiological analysis. Interestingly, not early-phase HU (53.0Ϯ19.4 versus 59.2Ϯ19.7), but the ⌬HU (5.6Ϯ10.2 versus 13.5Ϯ14.5) was significantly different between the 2 groups (Pϭ0.02). With regard to MR findings, symptomatic plaques had higher signal intensity than those with asymptomatic presentation on time of flight (66.7% versus 22.2%, Pϭ0.002) and for the T1-weighted image ratio (1.60Ϯ0.6 versus 1.26Ϯ0.3, Pϭ0.02).
Radiological Correlation Between MDCTA and MR Findings
We then assessed whether early-phase HU or ⌬HU correlates with MRI-based plaque vulnerability. Early-phase HU showed a very weak correlation (rϭϪ0.08, Pϭ0.54; Figure  2A ) with the T1-weighted imaging ratio. However, ⌬HU showed a significant correlation (rϭϪ0.56, PϽ0.0001; Figure  2B ) with the T1-weighted imaging ratio. On the other hand, there was no difference in early-phase HU for the presence of IPH defined by time of flight ( Figure 2C ). However, plaques without IPH had higher ⌬HU than plaques with IPH (PϽ0.0001; Figure 2D ). These results suggest that not earlyphase HU but ⌬HU could be a marker of LRNC and IPH. 
Correlation Between MDCTA and Pathological Findings
To confirm the significance of ⌬HU for plaque vulnerability, pathological analysis was performed. Twenty surgical specimens obtained from carotid endarterectomy clearly showed fibrous tissue and LRNC with hematoxylin and eosin, Azan, EVG, and Alcian blue staining. The ⌬HU, but not early-phase HU ( Figure 3A-B) , was positively correlated with fibrous tissue (rϭ0.67, Pϭ0.001; Figure 3C ) and negatively correlated with LRNC with hemorrhage (rϭϪ0.70, PϽ0.001; Figure 3D ). Representative images are shown in Supplemental Figures I and II.
We then investigated neovascularization and inflammation on the shoulder of the plaque because these components might affect HU and plaque vulnerability. Overall, interobserver reproducibility (N.H. and G.S.) and intraobserver reproducibility (N.H.; interval of 7 days) were substantial to nearly perfect for neovascularization grade ( coefficientϭ0.68 and 0.84, respectively) and inflammation grade ( coefficientϭ0.92 and 0.85, respectively). Interestingly, plaques with lower ⌬HU had lots of small vessels or large irregular vessels on the shoulder, and inflammatory cells were also observed (Supplemental Figure IIIA) , which was different from plaques with higher ⌬HU showing fewer vessels or less inflammatory cells (Supplemental Figure IIIB) . The correlation between ⌬HU and neovascularization (Supplemental Figure IIIC) or inflammation (Supplemental Figure  IIID) indicated that plaques with low-grade neovascularization and inflammation had higher ⌬HU, although a large distribution of values was noted.
Discussion Delayed Enhancement of the Contrast Media
In this study, we focused on plaque stability because fibrous components are stabilizing features of atherosclerotic plaques, and therefore quantification could qualify fibrous tissue as an important predictor of plaque stability. In some MRI studies, LRNC has been identified on postcontrast T1-weighted images as an area in the bulk of the plaque with no or slight contrast enhancement compared with surrounding, more strongly enhanced fibrous tissues. 6, 17, 24, 25, 29 Yuan et al analyzed percent increase in signal intensity of the different plaque types after contrast enhancement and concluded that contrast-enhanced MRI has the potential to differentiate LRNC (28.8% increase) from fibrous tissue (79.5% increase). 30 However, no previous reports have investigated plaque morphology based on the different enhancement pattern of contrast media in plaque components with MDCTA.
We analyzed the difference in HU from the early to delayed phase because this method has the potential to differentiate LRNC from fibrous tissue as well as contrastenhanced MRI, and it can also address the blooming effect of calcifications and substantial overlap between the attenuation values of plaque components. Our results clearly showed that ⌬HU was significantly correlated with symptomatic presentation and MRI-based plaque vulnerability. Moreover, histological analysis demonstrated that delayed absorption of the contrast media (higher ⌬HU) was observed in the fibrous component, which confirms our hypothesis.
Interpretation of Neovascularization and Inflammation
Neovascularization is also reported as a marker of plaque vulnerability. In the coronary field, it has been reported that pronounced enhancement of adventitial vasa vasorum is associated with established vascular events, supporting the concept that neovascularization is associated with plaque instability and vulnerability. 20, 23 However, there has been little consensus regarding "radiological neovascularization" because it is still difficult to define neovascularization with static imaging modalities. Only dynamic contrast-enhanced carotid ultrasound is able to show vasa vasorum and plaque neovascularization, which are associated with cerebrovascular events, 23 but there have been no previous reports clearly showing intraplaque neovascularization with MRI or MDCTA. It was reported that plaque neovascularization could be identified using a threshold of 80% enhancement in fibrous tissue with MRI, but there was a high SD in percent enhancement of neovascularization. 30 This could account for an overlap between the neovascularization with a peak in the early phase and the fibrous tissue with a peak in a delayed phase. Therefore, the interpretation of neovascularization depends on the timing of the scan in static imaging. Theoretically, contrast media can be observed in the lumen of new vessels in the early phase, and it gradually penetrates into the extravascular extracellular space circumferentially. Consistent with this, Kerwin et al showed that there is a rapidly enhancing component, which is parallel to a signal change in the vessel lumen (suggesting neovascularization), and a slowly enhancing component (suggesting fibrous tissue) in plaques with contrast-enhanced dynamic MRI. 29 In our study, plaques with a lower ⌬HU had multiple irregular or large vessels, and they also had massive inflammatory cells on the shoulder, although there was a wide distribution of values. Therefore, our results also suggest that plaques with low ⌬HU can show plaque neovascularization and surrounding inflammation as well as LRNC and IPH, which all indicate vulnerable plaques (Table 2) . Therefore, an increase in HU from the early to delayed phase indicates a lot of fibrous tissue and less LRNC, IPH, and neovascularization, which suggest plaque stability (Figure 4 ).
Limitations
Several limitations in this study should be addressed. First, disadvantages of MDCTA are radiation exposure and the need to administer radiological contrast. Second, this study did not quantify HU for the entire plaque volume because of technical difficulty. Care should be taken in interpreting the data because atherosclerotic components could be heterogeneous in the carotid plaque. We further confirmed that ⌬HU in all individual locations of the plaque showed a significant (PϽ0.0001) correlation with MRI and histological findings (Supplemental Figure IV) . Multislice analysis with MDCTA is recommended to obtain overall understanding of the plaque. Third, it is difficult to evaluate each plaque component separately with MDCTA. Nevertheless, MDCTA using the difference in HU between phases has great potential to determine plaque stability or vulnerability. It is worth reconsidering the role of MDCTA using the difference in HU between phases for the assessment of carotid plaque stability.
Conclusions
This study is the first to show the dynamic assessment of contrast media in the plaque components to evaluate plaque stability on MDCTA. An increase in HU from the early to delayed phase indicates plaque stability with more fibrous tissue and less LRNC, IPH, and neovascularization.
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MRI protocol
After a survey to determine the position of the carotid plaque, the following MR imaging sequences were used: (1) 
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